Is antiviral prophylaxis necessary to prevent hepatitis B virus (HBV) reactivation in patients with HBV-resolved infection receiving rituximab-containing chemotherapy?

J Clin Oncol. 2013 Dec 10;31(35):4480. doi: 10.1200/JCO.2013.52.1278. Epub 2013 Nov 12.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / adverse effects*
  • Antineoplastic Agents / adverse effects*
  • Antiviral Agents / therapeutic use*
  • Female
  • Guanine / analogs & derivatives*
  • Hepatitis B / virology*
  • Hepatitis B virus / drug effects*
  • Humans
  • Lymphoma / drug therapy*
  • Male
  • Virus Activation / drug effects*

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Antiviral Agents
  • Guanine